tiprankstipranks
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market
AURX
Nuo Therapeutics
RESEARCH TOOLSreports
Want to see AURX full AI Analyst Report?

Nuo Therapeutics (AURX) Financial Statements

11 Followers

Nuo Therapeutics Financial Overview

Nuo Therapeutics's market cap is currently $51.31M. The company's EPS TTM is $; its P/E ratio is -23.49; Nuo Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 3.31M$ 1.37M$ 608.52K$ 112.25K$ 0.00
Gross Profit$ 2.22M$ 1.06M$ 482.43K$ 93.04K$ 0.00
Operating Income$ -2.52M$ -2.46M$ -3.17M$ -3.32M$ -90.67K
EBITDA$ -2.36M$ -2.36M$ -3.06M$ -3.10M$ 0.00
Net Income$ -2.51M$ -2.32M$ -3.17M$ -3.03M$ -90.67K
Balance Sheet
Cash & Short-Term Investments$ 548.95K$ 283.71K$ 928.68K$ 2.05M$ 148.43K
Total Assets$ 1.85M$ 1.19M$ 1.88M$ 3.05M$ 149.93K
Total Debt$ 97.35K$ 164.21K$ 255.59K$ 335.05K$ 0.00
Net Debt$ -451.60K$ -119.51K$ -673.09K$ -1.72M$ -148.43K
Total Liabilities$ 2.80M$ 675.80K$ 838.73K$ 856.02K$ 672.47K
Stockholders' Equity$ -956.56K$ 513.71K$ 1.04M$ 2.19M$ -522.54K
Cash Flow
Free Cash Flow$ -1.14M$ -2.39M$ -3.18M$ -3.77M$ -13.00K
Operating Cash Flow$ -864.97K$ -2.23M$ -3.17M$ -3.71M$ -13.00K
Investing Cash Flow$ -274.76K$ -154.96K$ -7.24K$ -59.99K$ 0.00
Financing Cash Flow$ 1.40M$ 1.74M$ 2.00M$ 4.46M$ 1.37T
Currency in USD

Nuo Therapeutics Earnings and Revenue History

Income Statement >

Nuo Therapeutics Debt to Assets

Balance Sheet >

Nuo Therapeutics Cash Flow

Cash Flow >

Nuo Therapeutics Forecast EPS vs Actual EPS

Earnings >